Treatment of metastatic castration-resistant prostate cancer (mCRPC); Survival by type of progression at initiation of treatment

2018-10-01

Annals of Oncology , Volume 29 p. viii281- viii282

Additional Metadata
Persistent URL	doi.org/10.1093/annonc/mdy284.022, hdl.handle.net/1765/125543
Journal	Annals of Oncology
Organisation	Erasmus MC Cancer Institute
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Robbrecht, D.G. (D. G.), van Soest, R. J., Tannock, I., Oudard, S., Tombal, B., Eisenberger, M., … de Wit, R. (2018). Treatment of metastatic castration-resistant prostate cancer (mCRPC); Survival by type of progression at initiation of treatment. Annals of Oncology, 29, viii281–viii282. doi:10.1093/annonc/mdy284.022

Publication